The Impact of PF Ratio and Oxygenation on Non-Invasive Ventilation Failure during Acute Exacerbations of COPD
Abstract
Abstract
Background Chronic obstructive pulmonary disease (COPD) is a prevalent and potentially fatal illness characterized by restricted airflow in the airways and alveoli. Acute exacerbations of COPD have a significant negative impact on patients and contribute to increased mortality. Noninvasive ventilation (NIV) is increasingly used to manage this condition, but it can fail, leading to intubation and higher mortality rates. Recognition of factors contributing NIV failure is crucial to prevent morbidity and mortality. The PaO2/FiO2 ratio, a measure of oxygenation, has been studied in acute respiratory distress syndrome. This study aims to explore the role of the P/F ratio in predicting NIV failure during acute exacerbation of COPD.
Material and Methods: A Quasi Single Arm Study was conducted in Medical ICU and medicine ward of a tertiary care hospital, including 170 patients presenting with COPD acute exacerbations. Data collected proforma after informed consent for 6 months.
Results: The study included 170 patients with acute COPD exacerbation. Among them, 38% experienced non-invasive ventilation (NIV) failure. The mortality rate was 23.5%. Significant differences were observed in FiO2, SaO2, PaO2, and PF ratio between patients with and without NIV failure and mortality.
Conclusion: This study examined non-invasive ventilation (NIV) outcomes and mortality rates in patients with acute COPD exacerbation. The analysis of oxygenation parameters revealed significant differences between patients with and without NIV failure and mortality. These findings contribute to the understanding of treatment outcomes in acute COPD exacerbation and can help in clinical decision making. More researches can be conducted for further evaluation.
References
1. Yang W, Li F, Li C, Meng J, Wang Y. Focus on early COPD: definition and early lung development. International Journal of Chronic Obstructive Pulmonary Disease. 2021 Nov 25:3217-28. DOI: 10.2147/COPD.S338359
2. Machado A, Barusso M, De Brandt J, Quadflieg K, Haesevoets S, Daenen M, Thomeer M, Ruttens D, Marques A, Burtin C. Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review. Pulmonology. 2022 Jun 14. https://doi.org/10.1016/j.pulmoe.2022.04.004
3. Jie Cheng#, Min Lu#, Huijuan Sun, Yanjun. A survival analysis of patients with an acute exacerbation of chronic obstructive pulmonary disease discharged from the respiratory intensive care unit. Annals of Palliative Medicine. 2020. DOI:https://apm.amegroups.org/article/view/42710
4. Bonnevie T, Gravier FE, Fresnel E, Kerfourn A, Medrinal C, Prieur G, Combret Y, Muir JF, Cuvelier A, Debeaumont D, Reychler G. NIV is not adequate for high intensity endurance exercise in COPD. Journal of clinical medicine. 2020 Apr 8;9(4):1054.
5. Chen T, Bai L, Hu W, Han X, Duan J. Risk factors associated with late failure of noninvasive ventilation in patients with chronic obstructive pulmonary disease. Canadian Respiratory Journal. 2020 Oct 13;2020. https://doi.org/10.1155/2020/8885464
6. Ding M, Han X, Bai L, Huang S, Duan J. Impact of HACOR score on noninvasive ventilation failure in non-COPD patients with acute-on-chronic respiratory failure. Canadian Respiratory Journal. 2021 Jul 22;2021:17. https://doi.org/10.1155/2021/9960667
7. Duan J, Wang S, Liu P, Han X, Tian Y, Gao F, Zhou J, Mou J, Qin Q, Yu J, Bai L. Early prediction of noninvasive ventilation failure in COPD patients: derivation, internal validation, and external validation of a simple risk score. Annals of Intensive Care. 2019 Dec;9:1-0. https://doi.org/10.1186/s13613-019-0585-9
8. Korula PJ, Nayyar V, Stachowski E, Karuppusami R, Peter JV. An observational study on the practice of noninvasive ventilation at a tertiary level Australian intensive care unit. Australian Critical Care. 2020 Jan 1;33(1):89-96. https://doi. org/10.1016/j.aucc.2018.11.067.
9. Abraham SV, Azeez AK, Padmanabhan A. NIV failure in respiratory failure: an analysis. The Egyptian Journal of Bronchology. 2023 Dec;17(1):1-8. https://doi.org/10.1186/s43168-023-00203-8.
10. Scala R, Pisani L. Noninvasive ventilation in acute respiratory failure: which recipe for success?. European respiratory review. 2018 Sep 30;27(149). https://doi.org/10.1183/16000617.0029-2018
11. Liang YR, Lan CC, Su WL, Yang MC, Chen SY, Wu YK. Factors and Outcomes Associated with Failed Noninvasive Positive Pressure Ventilation in Patients with Acute Respiratory Failure. International Journal of General Medicine. 2022;15:7189.
12. Palanidurai, S., Phua, J., Chan, Y.H. et al. P/FP ratio: incorporation of PEEP into the PaO2/FiO2 ratio for prognostication and classification of acute respiratory distress syndrome. Ann. Intensive Care 11, 124 (2021). https://doi.org/10.1186/s13613-021-00908-3.
13. Babu S, Abhilash KP, Kandasamy S, Gowri M. Association between SpO2/FiO2 Ratio and PaO2/FiO2 Ratio in Different Modes of Oxygen Supplementation. Indian J Crit Care Med. 2021 Sep;25(9):1001-1005. doi: 10.5005/jp-journals-10071-23977. PMID: 34963717; PMCID: PMC8664040.
14. Hinke CF, Jörres RA, Alter P, Bals R, Bornitz F, Kreuter M, Herth FJ, Kahnert K, Kellerer C, Watz H, Budweiser S. Prognostic value of oxygenated hemoglobin assessed during acute exacerbations of chronic pulmonary disease. Respiration. 2021 May 5;100(5):387-94. https://doi.org/10.1159/000513440
15. Ghazala L, Hatipoğlu U, Devnani T, Covert E, Hanks J, Edwards K, Macmurdo M, Li M, Wang X, Duggal A. Duration of noninvasive ventilation is not a predictor of clinical outcomes in patients with acute exacerbation of COPD and respiratory failure. Can J Respir Ther. 2021 Aug 18;57:113-118. doi: 10.29390/cjrt-2021-021. PMID: 34447880; PMCID: PMC8372872.
16. Gómez CC, Ruiz NT, de la Villa Zamora B, González LB, Salmerón PP, Aragüés PL. Predictors of noninvasive mechanical ventilation weaning failure in the emergency department. Emergencias. 2021 Feb 1;33(1):9-14.
Copyright (c) 2026 Annals of Jinnah Sindh Medical University

This work is licensed under a Creative Commons Attribution 4.0 International License.